These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 30287893)
1. Capturing the statewide incidence of neonatal abstinence syndrome in real time: the West Virginia experience. Umer A; Loudin S; Maxwell S; Lilly C; Stabler ME; Cottrell L; Hamilton C; Breyel J; Mullins C; John C Pediatr Res; 2019 Apr; 85(5):607-611. PubMed ID: 30287893 [TBL] [Abstract][Full Text] [Related]
2. Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013. Stabler ME; Long DL; Chertok IR; Giacobbi PR; Pilkerton C; Lander LR J Rural Health; 2017 Jan; 33(1):92-101. PubMed ID: 26879950 [TBL] [Abstract][Full Text] [Related]
3. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System. West KD; Ali MM; Blanco M; Natzke B; Nguyen L Matern Child Health J; 2023 Dec; 27(Suppl 1):14-22. PubMed ID: 37219692 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with the prevalence of neonatal abstinence syndrome in West Virginia. Rogerson T; Houston A; Lyman G; Ogden J; Paschall K; Penaranda M; Rios A; Wetzel R; Horzempa J J Opioid Manag; 2018; 14(6):445-452. PubMed ID: 30629281 [TBL] [Abstract][Full Text] [Related]
5. Disparities in neonatal abstinence syndrome and health insurance status: A statewide study using non-claims real-time surveillance data. Umer A; Lilly C; Hamilton C; Breyel J; Allen L; Rompala A; Moore C; O'Dierno P; John C Paediatr Perinat Epidemiol; 2021 May; 35(3):330-338. PubMed ID: 33111385 [TBL] [Abstract][Full Text] [Related]
6. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida. Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694 [TBL] [Abstract][Full Text] [Related]
7. A longitudinal analysis of temporal and spatial incidence of neonatal abstinence syndrome in Ontario: 2003-2016. Dawson E; Lew J; Mauer-Vakil D; Van Dijk A; Belanger P; Moore KM J Opioid Manag; 2019; 15(3):205-212. PubMed ID: 31343722 [TBL] [Abstract][Full Text] [Related]
8. Elucidating the Relationship Between Maternal Diabetes and Neonatal Abstinence Syndrome: A 2017-2018 Project WATCH Study in Rural Appalachia. Jennings A; John C; Lilly C; Hamilton C; Umer A Adv Neonatal Care; 2022 Jun; 22(3):239-245. PubMed ID: 34138790 [TBL] [Abstract][Full Text] [Related]
9. Incidence of Neonatal Abstinence Syndrome Epidemic and Associated Predictors in Nevada: A Statewide Audit, 2016-2018. Batra K; Cruz P; Cross CL; Bhandari N; Abdulla F; Pharr JR; Buttner MP Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33396848 [TBL] [Abstract][Full Text] [Related]
10. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada. Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382 [TBL] [Abstract][Full Text] [Related]
13. Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013. Warren MD; Miller AM; Traylor J; Bauer A; Patrick SW; MMWR Morb Mortal Wkly Rep; 2015 Feb; 64(5):125-8. PubMed ID: 25674995 [TBL] [Abstract][Full Text] [Related]
14. Neonatal Abstinence Syndrome in East Tennessee: Characteristics and Risk Factors among Mothers and Infants in One Area of Appalachia. Erwin PC; Meschke LL; Ehrlich SF; Lindley LC J Health Care Poor Underserved; 2017; 28(4):1393-1408. PubMed ID: 29176103 [TBL] [Abstract][Full Text] [Related]
15. Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018. Kelty EA; Cumming CN; Preen DB Pharmacotherapy; 2022 May; 42(5):405-410. PubMed ID: 35342965 [TBL] [Abstract][Full Text] [Related]
16. Buprenorphine: a new player in neonatal withdrawal syndrome. Nanda S; Brant R; Regier M; Yossuck P W V Med J; 2015; 111(1):16-21. PubMed ID: 25665273 [TBL] [Abstract][Full Text] [Related]
17. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Patrick SW; Davis MM; Lehmann CU; Cooper WO J Perinatol; 2015 Aug; 35(8):650-5. PubMed ID: 25927272 [TBL] [Abstract][Full Text] [Related]
18. Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013. Okoroh EM; Gee RE; Jiang B; McNeil MB; Hardy-Decuir BA; Zapata AL Matern Child Health J; 2017 Jul; 21(7):1479-1487. PubMed ID: 28168591 [TBL] [Abstract][Full Text] [Related]
19. Maternal drug use and its effect on neonates: a population-based study in Washington State. Creanga AA; Sabel JC; Ko JY; Wasserman CR; Shapiro-Mendoza CK; Taylor P; Barfield W; Cawthon L; Paulozzi LJ Obstet Gynecol; 2012 May; 119(5):924-33. PubMed ID: 22525903 [TBL] [Abstract][Full Text] [Related]
20. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy. Hussaini KS; Garcia Saavedra LF Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]